BramlagePMesserCBitterlichN, et al.The effect of optimal medical therapy on 1-year mortality after acute myocardial infarction. Heart2010; 96: 604–609.
3.
ChoudhryNKGlynnRJAvornJ, et al.Untangling the relationship between medication adherence and post–myocardial infarction outcomes: Medication adherence and clinical outcomes. Am Heart J2014; 167: 51–58.
4.
LuHTNordinRAhmadWAW, et al.Sex differences in acute coronary syndrome in a multiethnic Asian population: Results of the Malaysian National Cardiovascular Disease database—Acute Coronary Syndrome (NCVD-ACS) registry. Glob Heart2014; 9: 381–390.
5.
WilkinsonCBebbODondoTB, et al.Sex differences in quality indicator attainment for myocardial infarction: A nationwide cohort study. Heart2019; 105: 516–523.
6.
ChewDPScottIACullenL, et al.National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the management of acute coronary syndromes 2016. Heart Lung Circ2016; 25: 895–951.
7.
EindhovenDCHiltADZwaanTC, et al.Age and gender differences in medical adherence after myocardial infarction: Women do not receive optimal treatment–The Netherlands claims database. Eur J Prev Cardiol2018; 25: 181–189.
8.
ChewDPJuergensCFrenchJ, et al.An examination of clinical intuition in risk assessment among acute coronary syndromes patients: Observations from a prospective multi-center international observational registry. Int J Cardiol2014; 171: 209–216.
9.
StehliJMartinCBrennanA, et al.Sex differences persist in time to presentation, revascularization, and mortality in myocardial infarction treated with percutaneous coronary intervention. J Am Heart Assoc2019; 8: e012161–e012161.
10.
KhanEBriegerDAmerenaJ, et al.Differences in management and outcomes for men and women with ST-elevation myocardial infarction. Med J Aust2018; 209: 118123–118123.
